Methapyrilene

Methapyrilene

SCHEMBL4902232

CN(C)CCN(Cc1cccs1)c1ccccn1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Methapyrilene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 3/20 0.80
CYP2D6 P10635 5/20 0.80
CHRM2 P08172 4/20 0.80
ADRA2A P08913 4/20 0.80
DRD1 P21728 4/20 0.80
SLC6A4 P31645 4/20 0.80
SLC6A3 Q01959 4/20 0.80
KCNH2 Q12809 4/20 0.80
SLC6A2 P23975 3/20 0.80
HTR2A P28223 3/20 0.80
CYP1A2 P05177 3/20 0.80
OPRM1 P35372 3/20 0.80
ADRA2B P18089 2/20 0.80
CHRM1 P11229 2/20 0.80
HTR2C P28335 2/20 0.80
HTR2B P41595 2/20 0.80
CHRM5 P08912 1/20 0.80
CYP2C9 P11712 1/20 0.80
NFKB1 P19838 1/20 0.80
HTR6 P50406 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methapyrilene SCHEMBL19209 0.89 CYP2D6 (1.00) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL498484 0.88 KDM4E (1.00) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL745149 0.88 CYP2D6 (0.97) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL1074644 0.87 CYP2D6 (0.95) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL28140755 0.83 CYP2D6 (0.86) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL7121305 0.83 CYP2D6 (0.86) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Methapyrilene SCHEMBL17979729 0.81 CYP2D6 (0.52) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Fumaric Acid SCHEMBL29895368 0.80 SMN1; SMN2 (0.62) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Pyrilamine SCHEMBL97902 0.77 SMN1; SMN2 (1.00) CYP2D6CHRM2ADRA2ADRD1SLC6A4
Pyrilamine SCHEMBL27430 0.77 SMN1; SMN2 (1.00) CYP2D6CHRM2ADRA2ADRD1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9492541-B2 Phenylepherine containing dosage form SOVEREIGN PHARMACEUTICALS, LLC (US) 2016-11-15 US claimed
US-20060057205-A1 Phenylepherine containing dosage form SOVEREIGN PHARMACEUTICALS, LTD. (US) 2006-03-16 US claimed
WO-2006022996-A2 DOSAGE FORM CONTAINING MULTIPLE DRUGS SOVEREIGN PHARMACEUTICALS, LTD. (US) 2006-03-02 WO claimed
EP-0081823-A1 Composition for reducing menstrual pain WHITBY RESEARCH, Inc. (US) 1983-06-22 EP claimed
US-4269835-A Nasal composition for relieving nasal distress WHITTLE BARRY J 1981-05-26 US claimed
US-10098856-B2 Alternating sympathomimetic therapy for the treatment of respiratory ailments SOVEREIGN PHARMACEUTICALS, LLC (US) 2018-10-16 US disclosed
US-9492541-B2 Phenylepherine containing dosage form SOVEREIGN PHARMACEUTICALS, LLC (US) 2016-11-15 US disclosed
US-20160271078-A1 ALTERNATING SYMPATHOMIMETIC THERAPY FOR THE TREATMENT OF RESPIRATORY AILMENTS SOVEREIGN PHARMACEUTICALS, LLC 2016-09-22 US disclosed
US-9364451-B1 Alternating sympathomimetic therapy for the treatment of respiratory ailments SOVEREIGN PHARMACEUTICALS, LLC (US) 2016-06-14 US disclosed
US-20150152348-A1 SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS SHARPS COMPLIANCE, INC. OF TEXAS 2015-06-04 US disclosed
US-8653135-B1 Alternating sympathomimetic therapy for the treatment of respiratory aliments SOVEREIGN PHARMACEUTICALS, LLC (US) 2014-02-18 US disclosed
US-20080292699-A1 SOLID PHARMACEUTICAL DOSAGE UNIT FOR ALLEVIATING SYMPTOMS OF RHINORRHEA SOVEREIGN PHARMACEUTICALS, LTD. (US) 2008-11-27 US disclosed
EP-0421582-A1 Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same WARNER-LAMBERT COMPANY (US) 1991-04-10 EP disclosed
EP-0421581-A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same WARNER-LAMBERT COMPANY (US) 1991-04-10 EP disclosed
EP-0403048-A2 Medicated compositions containing sucralfate and processes for their production WARNER-LAMBERT COMPANY (US) 1990-12-19 EP disclosed
US-4505862-A ANALGESICS, SLEEPING MEDICATIONS BRISTOL-MYERS COMPANY (US) 1985-03-19 US disclosed
US-4401665-A USING ASPIRIN AND/OR ACETAMINOPHEN MULTILAYER BRISTOL-MYERS COMPANY (US) 1983-08-30 US disclosed
EP-0081823-A1 Composition for reducing menstrual pain WHITBY RESEARCH, Inc. (US) 1983-06-22 EP disclosed
US-4364945-A ANTIHISTAMINE AND ISOMER OF VITAMIN E WHITTLE BARRY J 1982-12-21 US disclosed
US-4269835-A Nasal composition for relieving nasal distress WHITTLE BARRY J 1981-05-26 US disclosed